TransMedics Group/$TMDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TransMedics Group
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Ticker
$TMDX
Sector
Primary listing
Employees
898
Headquarters
Website
TMDX Metrics
BasicAdvanced
$2.6bn
16.99
$4.46
2.06
-
Price and volume
Market cap
$2.6bn
Beta
2.06
52-week high
$156.00
52-week low
$60.11
Average daily volume
1.7m
Financial strength
Current ratio
6.737
Quick ratio
6.01
Long term debt to equity
171.031
Total debt to equity
174.778
Interest coverage (TTM)
5.40%
Profitability
EBITDA (TTM)
125.349
Gross margin (TTM)
59.09%
Net profit margin (TTM)
27.04%
Operating margin (TTM)
14.85%
Effective tax rate (TTM)
-92.46%
Revenue per employee (TTM)
$710,000
Management effectiveness
Return on assets (TTM)
5.19%
Return on equity (TTM)
45.22%
Valuation
Price to earnings (TTM)
16.988
Price to revenue (TTM)
4.073
Price to book
5.3
Price to tangible book (TTM)
5.43
Price to free cash flow (TTM)
17.111
Free cash flow yield (TTM)
5.84%
Free cash flow per share (TTM)
4.431
Growth
Revenue change (TTM)
30.24%
Earnings per share change (TTM)
216.80%
3-year revenue growth (CAGR)
74.76%
3-year earnings per share growth (CAGR)
69.04%
What the Analysts think about TMDX
Analyst ratings (Buy, Hold, Sell) for TransMedics Group stock.
TMDX Financial Performance
Revenues and expenses
TMDX Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs